These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9467539)

  • 1. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    J Clin Endocrinol Metab; 1998 Feb; 83(2):348-52. PubMed ID: 9467539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa.
    Duclos M; Corcuff JB; Roger P; Tabarin A
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):725-31. PubMed ID: 10619977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The limited ability of inferior petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing's disease from pseudo-Cushing states or normal physiology.
    Yanovski JA; Cutler GB; Doppman JL; Miller DL; Chrousos GP; Oldfield EH; Nieman LK
    J Clin Endocrinol Metab; 1993 Aug; 77(2):503-9. PubMed ID: 8393887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone-suppressed corticotropin-releasing hormone stimulation test in morbid obese adults.
    Saiegh L; Keren D; Rainis T; Sheikh-Ahmad M; Reut M; Nakhleh A; Wirsansky I; Chen-Konak L; Schiff E; Shechner C
    Obes Res Clin Pract; 2016; 10(3):275-82. PubMed ID: 26277697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome.
    Valassi E; Swearingen B; Lee H; Nachtigall LB; Donoho DA; Klibanski A; Biller BM
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4851-9. PubMed ID: 19850679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism.
    Erickson D; Natt N; Nippoldt T; Young WF; Carpenter PC; Petterson T; Christianson T
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2972-6. PubMed ID: 17488798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome.
    Nieman LK; Chrousos GP; Oldfield EH; Avgerinos PC; Cutler GB; Loriaux DL
    Ann Intern Med; 1986 Dec; 105(6):862-7. PubMed ID: 3022629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Martin NM; Dhillo WS; Banerjee A; Abdulali A; Jayasena CN; Donaldson M; Todd JF; Meeran K
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2582-6. PubMed ID: 16670165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.
    Gatta B; Chabre O; Cortet C; Martinie M; Corcuff JB; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
    Pecori Giraldi F; Invitti C; Cavagnini F;
    Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.